 The purpose of this study is to characterize the pharmacokinetics how drugs are absorbed in the body, how they are distributed within the body and how they are removed from the body over time of ceftobiprole after a single 250-mg intravenous IV infusion given directly into the vein for 2 hours, before and after dialysis to patients with end-stage renal disease ESRD requiring hemodialysis or healthy volunteers. 